Chung Jae-Yong
Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam 13620, Korea.
Transl Clin Pharmacol. 2019 Mar;27(1):6-11. doi: 10.12793/tcp.2019.27.1.6. Epub 2019 Mar 27.
Digital therapeutics (DTx) is a new subsection of digital health that is primarily driven by software and will be of great interest to clinical pharmacologists. In this article, an overview of DTx, including definition, position in the landscape of therapeutics, product categories, benefits, and challenges, is provided. Discussions from the point of view of clinical pharmacology are presented, as DTx should have exposure-response relationships. The principles of clinical pharmacology can be applied to DTx as they are comparable to pharmacotherapy. Clinical pharmacology has great potential in the development, application, and regulation of DTx.
数字疗法（DTx）是数字健康的一个新分支，主要由软件驱动，临床药理学家将对其产生浓厚兴趣。本文提供了数字疗法的概述，包括定义、在治疗领域的地位、产品类别、益处和挑战。从临床药理学的角度进行了讨论，因为数字疗法应具有暴露-反应关系。临床药理学的原理可应用于数字疗法，因为它们与药物治疗具有可比性。临床药理学在数字疗法的开发、应用和监管方面具有巨大潜力。
